William Blair President and Chief Executive Officer Brent Gledhill and Chairman Emeritus John Ettelson were named to Crain’s Chicago’s list of “Who’s Who” in Chicago business 2024.
Corporate
Gledhill, Ettelson Named “Who’s Who” by Crain’s Chicago
Delivered to Your Inbox
Stay up-to-date with the latest William Blair news and insights
Our Latest News
-
Aardvark Therapeutics, Inc.: Initiation of Research Coverage
William Blair initiated research coverage of Aardvark Therapeutics, Inc. (AARD $13.98). Aardvark is advancing ARD-101, an oral therapy that targets bitter taste receptors (TAS2Rs) in the gastrointestinal tract, and ARD-201, a combination of ARD-101 and a DPP-4 inhibitor, for treating Prader-Willi syndrome (PWS) and obesity, respectively.
-
-